from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2448c/valS

LFCtreatmentdescriptionclass of inhibitor

-1.503

Amikacinug/mL Amikacintranslation

-1.216

Cap5-10ug/mL Capreomycintranslation

-1.973

Rox10-50 ug/mL Roxithromycintranslation

0.688

SM2-5 ug/mL Streptomycintranslation

-2.969

Tet5-10 ug/mL Tetracyclinetranslation

-1.988

Rif0.2-5ug/mL Rifampicintranscription

-0.268

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.144

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.646

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.303

CPZ10-50 ug/mL Chlorpromazinerespiration

0.220

Clofazimine10-13 ug/mL Clofaziminerespiration

0.672

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.403

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.658

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.897

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.665

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.190

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.798

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.295

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.033

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.767

KCN5-20 ug/mL Potassium cyaniderespiration

1.730

NaN30.2-2 mM Sodium aziderespiration

1.071

Nigericin50 uM Nigericinrespiration

-0.818

TRC10-150 ug/mL Triclosanrespiration

-0.766

TRZ10-25 ug/mL Thioridazinerespiration

-0.544

Valinomycin0.5-10 uM Valinomycinrespiration

0.761

ZnSO42 mM ZnSO4respiration

0.326

menadione6-10 ug/mL Menadionerespiration

-0.623

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.149

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.451

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.437

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.929

NRP_1Non-replicating persistence stage 1dosRassociated

0.130

Amp0.2mg/mL AmpicillincellWall

0.039

Cephalexin20-100 ug/mL CephalexincellWall

0.537

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.770

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.575

EMB10-20 ug/mL EthambutolcellWall

0.212

Eta12-40 ug/mL EthionamidecellWall

-0.192

INH0.2-0.4 ug/mL IsoniazidcellWall

0.460

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.293

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.357

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.810

BZA0.12 mg/mL BenzamidearomaticAmides

0.960

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.826

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.491

H2O24 mM hydrogen peroxideDNAdamaging

0.916

Levo10 ug/mL LevofloxacinDNAdamaging

0.377

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.343

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.283

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.396

UVUV-irradiationDNAdamaging

-1.581

ARP41-4 ug/mL Antitubercular compound ARP4?

0.334

Antimycin12.5-50 ug/mL Antimycin A?

0.272

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.891

PA_110-50 ug/mL Antitubercular compound PA-1?

0.793

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.518

PA8240.2-2 ug/mL PA-824?

1.100

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.090

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.234

Verapamil50 uM Verapamil?

-0.044

mercaptoethanol2 mM 2-Mercaptoethanol?

0.655

methoxatin10-20 ug/mL Methoxatin?